why choose us

First received: February 05, 2024

Clinical Trial: A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL

Brief Summary: Trial design: A single centre phase II non-randomised studyTrial population: Men with intermediate risk localised prostate cancerRecruitment target: 20 patients in totalTrial objectives:* Primary To develop a 5 fraction de-escalated dose SBRT protocol capable of reducing side effects* Secondary * To assess levels of acute GU and GI toxicity (CTCAE) * To assess levels of late GU and GI toxicity (CTCAE) * To assess late sexual quality of life (expanded EPIC, IIEF-5) * To assess biochemical relapse-free survival at 2…

Read more